GENE ONLINE|News &
Opinion
Blog

Feature
Moving Past Animal Models with Better Data for Drug Discovery
2022-11-23
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
Hemgenix Marks Most Expensive Treatment Ever and First Gene Therapy for Hemophilia B
In a historic moment, CSL Behring’s one-time gene therapy infusion, Hemgenix, received FDA approval to treat eligible adults with Hemophilia B. The revolutionary therapy marks …

Home Read More »

2022-11-22
Provention’s Tzield Snags FDA’s Approval to Slow Type 1 Diabetes Progression
2022-11-20
Special
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
After receiving a Complete Response Letter (CLR) from the FDA for its non-small cell lung cancer drug (NSCLC), poziotinib, Spectrum Pharmaceuticals announced its intention to …

Spectrum to Cut 75% of Staff and NSCLC Program Following CLR Read More »

2022-11-28
BioFuture NYC 2022: Using Technology to Prepare for an Aging Population
With 10,000 baby boomers turning 65 every day, the U.S. must consider this aging population's future and its effects on the healthcare system. At BioFuture NTC 2022, four industry-leading experts spoke about the weight the American healthcare system will face soon and what steps it might take to prepare for the tidal wave of care concerns. The panel mentioned concerns surrounding insurance systems, the scope of healthcare impact, leveraging technology to society’s advantage, and much more. 
Moderated by David Hancock, an analytics expert from SAS institute, the panel included:

2022-11-22
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates
“How does vision become reality?” Illumina CEO Francis deSouza posed this question at the beginning of the 2022 Illumina Genomics Forum hosted in San Diego, …

Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates Read More »

2022-11-17Partner
LATEST
Axsome’s AXS-05 Achieves Endpoints In Alzheimer’s Agitation Trial
2022-11-29
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
2022-11-28
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan
2022-11-28
GenFleet Therapeutics to Present Data from Phase I Trial of GFH009 Monotherapy at the 2022 Annual Meeting of American Society of Hematology (ASH)
2022-11-28
Everest’s Renal Drug Gets Placed On Fast Track For Approval In Taiwan And Korea
2022-11-28
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
Deals
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Nineteen Grants and Two Contracts Grab $38 Million In Support From the FDA
2022-10-17
Andera Partners Drums Up $443 Million For Its Largest Life Sciences Fund
2022-10-11
Alkermes to Break Oncology Sector into Independent Company
2022-11-03
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Merck Expands Hematology Portfolio With $1.35 Billion Imago Buy
2022-11-22
Kriya Scoops Up Redpin to Break into Neurology Gene Therapies
2022-11-16
Indivior Buys Opiant For $145 Million, Adds Opioid Overdose Treatments To Portfolio
2022-11-15
Ranking & Reports
2026: The Promise of Synthetic Biology
2022-08-11
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
Categories
Transforming Southern California Biotech Landscape: An Interview With SoCalBio CEO Ahmed Enany
2022-10-18
Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene
2022-10-05
Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy
2022-09-15
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Axsome’s AXS-05 Achieves Endpoints In Alzheimer’s Agitation Trial
2022-11-29
Everest’s Renal Drug Gets Placed On Fast Track For Approval In Taiwan And Korea
2022-11-28
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
China’s Tenacia Books Marinus For $266 Million To Market Seizure Med
2022-11-20
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Coastar Therapeutics Receives Venture Capital Investment to Further Develop Delivery Technology of Biologics for Cancer and Gene Therapies
2022-11-10Partner
Boston’s Manifold Bio Secures $40M to Tackle Translational Obstacles
2022-07-15
US Bio-Entrepreneur Program Launches in the UK
2022-06-30
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
Government Agencies Spring into Action After Biomanufacturing Executive Order
2022-09-14
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
Kite to Use Refuge’s Gene Expression Platform for New CAR-T Therapies
2022-10-21
Pfizer Opts In On Neurological Target In Voyager Deal, Leaving $290 Million In Milestones
2022-10-05
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
Prenatal Enzyme Therapy Could Help Treat Rare Genetic Disease
2022-11-21
Combining STING Agonists and pHLIPs to Enhance Cancer Treatments
2022-11-09
Growing Number of Monkeypox Tests Available to Researchers
2022-08-22
Taiwan’s CancerFree Bio Showcases World’s First Commercialized Personalized Cancer Profile
2022-08-01
BD, CerTest Commercialize Research-Use Monkeypox Test Amidst Rising Cases
2022-07-29
EVENT
2022-12-01
BIOCHINA 2022
Online
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!